Evaluating Drug–Drug Interactions in Cancer Patients Receiving Anticoagulants and Antineoplastics
Despoina Pantazi, Teaching Staff at the Department of Chemistry, University of Ioannina, shared a post on LinkedIn:
“Take a look at my new article!
“Evaluating DDIs in cancer patients receiving anticoagulants and antineoplastics: a scoping review focusing on therapeutic efcacy and safety”
Medical Oncology (2025) 42:511
Many thanks to all participants in this work:
The oncologists:
Dr Melina Gerolatsite, Nanteznta Torounidou, Prof Davide Mauri, and Dr Nikos Tsoukalas
The hematologists:
Prof Grigoris Gerotziafas and Prof Elmina Lefkou
The cardiologist:
Costas Pappas, University Hospital of Ioannina
And
Emeritus professor Alexandros Tselepis for his comments.”
Title: Evaluating DDIs in cancer patients receiving anticoagulants and antineoplastics: a scoping review focusing on therapeutic efficacy and safety
Authors: Melina Yerolatsite, Nikolaos Tsoukalas, Grigoris Gerotziafas, Costas Pappas, Nanteznta Torounidou, Eleftheria Lefkou, Davide Mauri, Alexandros D. Tselepis, Despoina Pantazi
Read full article here.
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal
-
Aug 26, 2026, 14:46Holly O’Byrne: A Framework for Developing and Managing Prehospital Blood Programs
-
Aug 26, 2026, 14:32Eleftherios Mylonakis: Earlier Intervention, Better Risk Stratification, Stronger BP Control
-
Aug 26, 2026, 14:32Bringing ISTH 2026 Research to the Global Scientific Community
-
Aug 26, 2026, 14:18Thomas Dayspring: Prognostic Impact of Lp(a) Changes Following Statin Therapy in Patients with CAD
-
Aug 26, 2026, 14:17Khurram Nasir: Are We Debating the Wrong Thing About Research in Medical Training?
-
Aug 26, 2026, 14:15Nathan Connell: Why Format Free Publishing Still Demands Formatting?
-
Aug 26, 2026, 14:14Reza Shojaei: China’s Reliance on Imported Albumin Raises Global Plasma Security Concerns
-
Aug 26, 2026, 14:03Ahmad Masri: The Amyloid Depleter Revolution in ATTR-CM